Asia · Regional markets · CNBC-TV18

Aurobindo Pharma Q2 profit rises 33%, beats estimates; declares ₹7 interim dividend

Published by CNBC-TV18 · India 1 h ago

Aurobindo Pharma reported a 32.8% year-on-year increase in consolidated net profit to ₹1,126 crore for the second quarter of FY27, compared with ₹848 crore in the corresponding…

Read the full article on CNBC-TV18 Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.cnbctv18.com)

Also worth reading

Mint

Wall Street cheers US midterm results as Dow Jones jumps 1300 points; Amazon, Apple, Microsoft among top gainers

The Straits Times Business

Mainstream car COE charges to new record, outstrips luxury category as car show drives demand

Vietnam Investment Review

Aurobindo Pharma Q2 profit rises 33%, beats estimates; declares ₹7 interim dividend

Share

Also worth reading

Wall Street cheers US midterm results as Dow Jones jumps 1300 points; Amazon, Apple, Microsoft among top gainers

Wall Street rallies after Democrats win Congress; data centre stocks slide

Suppliers charging vendors extra for UPI payments before MDR: ISB survey

SG AI startup Featherless to add MiniMax M3.1 Flash for coding

Mainstream car COE charges to new record, outstrips luxury category as car show drives demand

Vietnam's climate tech startups face gaps in funding